F.D.A. to Relabel Leucovorin for Autism Treatment

The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *